HPQ Silicon Closed over $1.0 Million Non-Brokered Private Placement

Core Insights - HPQ Silicon Inc. has successfully closed a non-brokered private placement of 6,170,442 common shares at a price of $0.1625 per share, raising gross proceeds of $1,002,696.83 [1] - The funds will be used to advance the commercialization of HPQ's core technology platforms, including Fumed Silica Reactor, HPQ ENDURA+™, and METAGENE™ [4][6] Private Placement Details - All securities issued under the private placement are subject to a statutory hold period of four months and one day from the closing date [2] - HPQ will pay commissions by issuing 333,303 warrants to CI Investment Services Inc., with each warrant allowing the purchase of one common share at an exercise price of $0.18 for 48 months [3] Management Participation - Bernard Tourillon, the Chairman, President, and CEO, subscribed for 615,384 common shares, representing an investment of $99,999.90, increasing his ownership to approximately 5.29% of the company's shares [4][5] Technology Development Focus - The company is focusing on client-driven commercial scale-up opportunities and revenue generation pathways through its Fumed Silica Reactor [6] - HPQ ENDURA+™ aims to commercialize lithium-ion cells and advance silicon-based anode material programs [6] - The METAGENE™ platform is focused on developing autonomous green hydrogen production technology [6] Strategic Vision - Tourillon expressed confidence in the company's ability to execute its near-term priorities and create long-term value, emphasizing the importance of the funds in maintaining momentum and advancing milestones [7] - HPQ Silicon is positioned to capture growth opportunities in energy storage, clean hydrogen, and advanced materials markets, which are essential for achieving global net-zero goals [10]